Skip to main navigation

> Main Menu

About Our Company Our History Our Mission, Vision, Values Our Leadership

Integrity

Contact

Investors Overview News Events Letters to Stockholders Corporate Governance SEC Filings & Financials Stock Information Investor Resources

> Main Menu

About

Our Company Our History Our Mission, Vision, Values Our Leadership

Integrity Contact

Investors

Overview News Events Letters to Stockholders Corporate Governance SEC Filings & Financials Stock Information Investor Resources

Press Releases

Year

June 17, 2021

Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

June 14, 2021

Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026

June 14, 2021

Harrow Health Announces Offering of $17.5 Million of 8.625% Senior Notes Due 2026 and “BB” Rating from Egan-Jones

June 3, 2021

Visionology Acquires Exclusive Worldwide License to SPARCS Contrast Sensitivity Testing Technology

June 1, 2021

Harrow Health Launches New Corporate and Investor Website

May 17, 2021

Leading Peer-Reviewed Ophthalmic Journal Publishes Study on ImprimisRx’s Proprietary Klarity-C® Drops

May 11, 2021

Harrow Health Announces Record First Quarter 2021 Financial Results

May 5, 2021

Harrow Health Raises Approximately $11 Million in Sale of Series B Preferred Stock

May 5, 2021

Harrow Health Announces Full Exercise and Closing of Option to Purchase Additional Senior Notes

April 27, 2021

Harrow Health to Announce First Quarter 2021 Financial Results on May 11, 2021

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 17

Address

102 Woodmont Blvd., Suite 610
Nashville, TN 37205

Phone

(615) 733 4730
(615) 733 4737 (Investor Relations)

Social

© 2021 Harrow Health, Inc.

> Footer

Privacy Policy Cookie Notice